Blog: Nestle receives green light on Pfizer deal

Michelle Russell | 6 November 2012

Swiss food group Nestle today (6 November) received approval from the Chinese Ministry of Commerce for its US$11.85bn deal to acquire Pfizer's infant nutrition business.

The approval brings Nestle another step closer to completing the acquisition, which was announced in April this year, enabling the world's largest infant nutrition group to extend its lead in this fast-growing category.

Pfizer Nutrition operates in more than 60 countries globally and 85% of sales are generated in emerging markets, meaning the acquisition effectively fills in the blanks on the map for Nestle. It will provide the company with increased scale in a high-growth, high-margin, category in fast-growing developing markets, CEO Paul Bulcke told investors as it emerged as victor of competitive auction process.

Nestle beat companies including Danone and Mead Johnson to seal the agreement. The next hurdle, however, is to receive approval from anti-trust bodies in several countries in order to fully complete the acquisition.


BLOG

Tate & Lyle shakes up Splenda unit

Amid significant pressure on profits from its Splenda sucralose business, UK-based food ingredients group Tate & Lyle has this morning (21 April) announced plans to try to "maximise returns"....

BLOG

US campaigners lobby FDA on GRAS rules

Four campaign groups in the US have urged the country's Food and Drug Administration to close a "loophole" in regulations on food additives and bring the rules - due to be finalised by August next yea...

BLOG

Cargill unveils first landfill-free facility

The Cargill meat processing facility in Hazleton, Pa., has become the company's first certified landfill-free production site. ...

just-food homepage



Forgot your password?